RHRyota Hyodo

Ryota Hyodo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ryota Hyodo has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Shinji Naganawa

    Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    7 shared publications
  • Yasuo Takehara

    Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Fundamental Development for Advanced Low Invasive Diagnostic Imaging, Nagoya University Graduate School of Medicine, Nagoya, Japan

    7 shared publications
  • Kazushige Ichikawa

    6 shared publications
  • Takashi Mizuno

    Department of Radiological Technology, Nagoya University Hospital, Nagoya, Japan

    5 shared publications
  • Ryota Horiguchi

    Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    4 shared publications
  • Shinji Naganawa

    Department of Radiology, Nagoya University Graduate School of Medicine, Japan

    4 shared publications

Latest Publications

  • Four-dimensional flow MRI demonstrates portal flow redistribution associated with hepatic function after retrograde transvenous obliteration

    by Ryota Hyodo, Yoji Ishizu, Ryota Horiguchi, Mami Iima, Yasuo Takehara, Shinya Yokoyama, Takashi Mizuno, Daniel Giese, Akihiro Manabe, Shinji Naganawa

  • Diagonal DWI : A Time‐Efficient Alternative to 3‐Scan Trace DWI for Breast Lesion Evaluation at 3.0‐T MRI —A Phantom Study and Clinical Assessment

    by Yusuke Jo, Yuki Sato, Mami Iima, Hiroko Satake, Yunhao Zhang, Yutaka Kato, Satoko Ishigaki, Ryota Hyodo, Aki Mano, Yoshito Ichiba, et al.

    Background: Diffusion‐weighted imaging (DWI) in breast MRI requires balancing image quality with acquisition time. Reducing scan time without sacrificing diagnostic performance could improve patient comfort and workflow. Purpose: To compare 3‐scan trace DWI (tDWI) and diagonal DWI (dDWI) for breast lesion evaluation using both phantom and clinical assessments, focusing on image quality metrics and diagnostic performance. Study Type: Retrospective comparative study. Population: A commercially available breast diffusion phantom (Caliber MRI; Boulder, CO, USA) and 92 consecutive participants were initially enrolled. After excluding 23 due to having no confirmed lesion, and 15 with non‐mass lesions, 54 patients (median age 55.5 years, range 21–82) were analyzed. Field Strength/Sequence: 3‐T, tDWI (120 s) and dDWI (74 s) with identical parameters except for diffusion gradient directions, with dDWI reducing scan time by 38%. Assessment: Phantom studies measured apparent diffusion coefficient (ADC) and estimated signal‐to‐noise ratio (eSNR). Clinical studies evaluated ADC, contrast‐to‐noise ratio (CNR), and contrast ratio (CR) from ROIs in lesions, normal breast tissue, and fat. Three radiologists scored lesion conspicuity and image quality. Statistical Tests: Due to non‐normal data distribution, the Wilcoxon signed‐rank test compared metrics between sequences. The ADC coefficient of variation (CV) was calculated. A p ‐value < 0.05 was considered significant. Results: dDWI significantly improved image quality by reducing artifacts, especially those originating from the nipple and in the breast tissue periphery, and slightly better lesion conspicuity. No significant difference was found for eSNR in breast phantom studies ( p = 0.31 for b = 0; and p = 0.84 for b = 800 s/mm 2 ). tDWI demonstrated significantly higher CNR for breast tissue and fat. tDWI also showed lower CR values for tumor/breast tissue and lower values for tumor/fat. ADC measurements were similar between techniques (CV = 4.20%). Data Conclusion: dDWI provides a 38% shorter acquisition time than tDWI while maintaining comparable quantitative performance. dDWI demonstrates improved image quality, particularly in challenging anatomical regions, though tDWI yields higher contrast‐to‐noise ratio values. Evidence Level: 3. Technical Efficacy Stage: 2.


  • Open Access

    Fully automated portal venous system segmentation from 4D flow MRI using 3D nnU-Net

    by Ryota Hyodo, Rintaro Ito, Ryota Horiguchi, Shohei Miyazaki, Daiki Tamashiro, Takashi Mizuno, Kazushige Ichikawa, Mami Iima, Yoji Ishizu, Yasuhiro Ogura, et al.


  • Evaluation of 4D Flow MRI‐Derived Relative Residence Time as a Marker for Cirrhosis Associated Portal Vein Thrombosis

    by Ryota Hyodo, Yasuo Takehara, Yoji Ishizu, Kazuki Nishida, Takashi Mizuno, Kazushige Ichikawa, Ryota Horiguchi, Nobuhiko Kurata, Yasuhiro Ogura, Shinya Yokoyama, et al.

    Background: Portal vein thrombosis (PVT) is thought to arise from stagnant blood flow, yet conclusive evidence is lacking. Relative residence time (RRT) assessed using 4D Flow MRI may offer insight into portal flow stagnation.Purpose: To explore the relationship between RRT values and the presence of PVT in cirrhotic participants.Study Type: Prospective.Population: Forty‐eight participants with liver cirrhosis (27 males, median age 67 years [IQR: 57–73]) and 20 healthy control participants (12 males, median age 45 years [IQR: 40–54]).Field Strength/Sequence: 3 T/4D Flow MRI.Assessment: Laboratory (liver and kidney function test results and platelet count) and clinical data (presence of tumors and other imaging findings), and portal hemodynamics derived from 4D Flow MRI (spatiotemporally averaged RRT [RRT‐mean], flow velocity, and flow rate) were analyzed.Statistical Tests: We used multivariable logistic regression, adjusted by selected covariates through the Lasso method, to explore whether RRT‐mean is an independent risk factor for PVT. The area under the ROC curve (AUC) was also calculated to assess the model's discriminative ability. P < 0.05 indicated statistical significance.Results: The liver cirrhosis group consisted of 16 participants with PVT and 32 without PVT. Higher RRT‐mean values (odds ratio [OR] 11.4 [95% CI: 2.19, 118]) and lower platelet count (OR 0.98 per 1000 μL [95% CI: 0.96, 0.99]) were independent risk factors for PVT. The incorporation of RRT‐mean (AUC, 0.77) alongside platelet count (AUC, 0.75) resulted in an AUC of 0.84. When including healthy control participants, RRT‐mean had an adjusted OR of 12.4 and the AUC of the combined model (RRT‐mean and platelet count) was 0.90.Data Conclusion: Prolonged RRT values and low platelet count were significantly associated with the presence of PVT in cirrhotic participants. RRT values derived from 4D Flow MRI may have potential clinical relevance in the management of PVT.Evidence Level: 2Technical Efficacy: Stage 2


  • Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization

    by Ryota Hyodo, Yasuo Takehara, Takashi Mizuno, Kazushige Ichikawa, Ryota Horiguchi, Shoji Kawakatsu, Tomoki Ebata, Shinji Naganawa, Ning Jin, Yoshito Ichiba

    Background Percutaneous transhepatic portal vein (PV) embolization (PVE) is a standard preoperative procedure for advanced biliary cancer when the future liver remnant (FLR) is insufficient, yet the effect of this procedure on portal hemodynamics is still unclear. Purpose To assess whether four-dimensional (4D) MRI flowmetry can be used to estimate FLR volume and to identify the optimal time for this measurement. Materials and Methods This prospective single-center study enrolled consecutive adult patients with biliary cancer who underwent percutaneous transhepatic PVE for the right liver between June 2020 and November 2022. Portal hemodynamics were assessed using 4D flow MRI before PVE and within 1 day (0-day group) or 3-4 days (3-day group) after PVE. FLR volume was measured using CT before PVE and after PVE but before surgery. Blood flow changes were analyzed with the Wilcoxon signed rank test, and correlations with Spearman rank correlation. Results The 0-day group included 24 participants (median age, 72 years [IQR, 69-77 years]; 17 male participants), and the 3-day group included 13 participants (median age, 71 years [IQR, 68-78 years]; eight male participants). Both groups showed increased left PV (LPV) flow rate after PVE (0-day group: from median 3.72 mL/sec [IQR, 2.83-4.55 mL/sec] to 9.48 mL/sec [IQR, 8.12-10.7 mL/sec], P < .001; 3-day group: from median 3.65 mL/sec [IQR, 2.14-3.79 mL/sec] to 8.16 mL/sec [IQR, 6.82-8.98 mL/sec], P < .001). LPV flow change correlated with FLR volume change relative to the number of days from PVE to presurgery CT only in the 3-day group (ρ = 0.62, P = .02; 0-day group, P = .11). The output of the regression equation for estimating presurgery FLR volume correlated with CT-measured volume (ρ = 0.78; P = .002). Conclusion Four-dimensional flow MRI demonstrated increased blood flow in residual portal branches 3-4 days after PVE, offering insights for estimating presurgery FLR volume. Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Roldán-Alzate and Oechtering in this issue.


  • Open Access

    Assessing the Complicated Venous Hemodynamics and Therapeutic Outcomes of Budd-Chiari Syndrome with Respiratory-gated 4D Flow MR Imaging During the Expiratory and Inspiratory Phases

    by Ryota Hyodo, Yasuo Takehara, Takashi Mizuno, Kazushige Ichikawa, Shinya Yokoyama, Yoji Ishizu, Shinji Naganawa

    A man in his 50s with Budd-Chiari syndrome diagnosed with the suprahepatic inferior vena cava (IVC) obstruction on CT was assessed using 4D Flow MRI before and after balloon angioplasty. 4D Flow MRI acquired in two respiratory phases, depicted complex hemodynamic and respiratory variability, and a jet stream at the narrowed channel of the membranous IVC. Post-interventional 4D Flow MRI showed that the IVC blood flow increased with corrected flow directions in the infrarenal IVC.


  • Open Access

    “Speckled Enhancement” on Gd-EOB-DTPA Enhanced MR Imaging of Primary Hepatic Mucosa-associated Lymphoid Tissue Lymphoma

    by Ryota Hyodo, Yasuo Takehara, Ayumi Nishida, Masaya Matsushima, Shinji Naganawa

    Purpose: To elucidate MRI features of primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma, particularly, the “speckled enhancement” on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.Methods: The institutional review board approved this retrospective observational study and waived informed consent. Using our picture archiving and communication systems and electronic medical records, five patients histopathologically diagnosed as hepatic MALT lymphoma and clinically confirmed as primary lesions who had undergone dynamic contrast-enhanced (DCE)-CT and DCE-MRI with Gd-EOB-DTPA were identified from September 2009 to December 2020. Two radiologists assessed their CT and MRI data in consensus with a pathologist’s advice.Results: Overall, five lesions in five patients were included in this study. Precontrast CT showed hypoattenuation in all lesions. In the arterial phase of DCE-CT, four lesions (80%) showed hyperattenuation, whereas all lesions showed iso- to hypoattenuation in the delayed phase. A vessel penetration sign was also observed in all lesions. On MRI, all lesions showed hypointensity on T1-weighted images, hyperintensity on T2-weighted images, and restricted diffusion on diffusion-weighted images. Both DCE-CT and DCE-MRI with Gd-EOB-DTPA showed similar enhancement patterns, except for the hepatocyte phase. Notably, however, four out of five lesions showed characteristic “speckled enhancement” that refers to punctate positive enhancements within the low signal lesions on the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI pathologically confirmed to be hepatocyte clusters that remained in the tumor.Conclusion: Primary hepatic MALT lymphomas were characterized by arterial phase enhancement, restricted diffusion, vessel penetration sign, and more specifically “speckled enhancement” in the hepatobiliary phase of DCE-MRI with Gd-EOB-DTPA.


  • Open Access

    4D Flow MRI in the portal venous system: imaging and analysis methods, and clinical applications

    by Ryota Hyodo, Yasuo Takehara, Shinji Naganawa

    Thus far, ultrasound, CT, and 2D cine phase-contrast MRI has been adopted to evaluate blood flow and vascular morphology in the portal venous system; however, all these techniques have some shortcomings, such as limited field of view and difficulty in accurately evaluating blood flow. A new imaging technique, namely 3D cine phase-contrast (4D Flow) MRI, can acquire blood flow data of the entire abdomen at once and in a time-resolved manner, allowing visual, quantitative, and comprehensive assessment of blood flow in the portal venous system. In addition, a retrospective blood flow analysis, i.e., "retrospective flowmetry," is possible. Although the development of 4D Flow MRI for the portal system has been delayed compared to that for the arterial system owing to the lower flow velocity of the portal venous system and the presence of respiratory artifacts, several useful reports have recently been published as the technology has advanced. In the first part of this narrative review article, technical considerations of image acquisition and analysis methods of 4D Flow MRI for the portal venous system and the validations of their results are described. In the second part, the current clinical application of 4D Flow MRI for the portal venous system is reviewed.


  • Time‐resolved 3D cine phase‐contrast magnetic resonance imaging (4D‐flow MRI) can quantitatively assess portosystemic shunt severity and confirm normalization of portal flow after embolization of large portosystemic shunts

    by Ryota Hyodo, Yasuo Takehara, Takashi Mizuno, Kazushige Ichikawa, Yoji Ishizu, Masataka Sugiyama, Shinji Naganawa

    Diagnosis and severity assessments of portosystemic shunts (PSSs) are important because the pathology sometimes results in severe hepatic encephalopathy, which can be treated almost completely by shunt embolization. At present, morphological assessment of PSS is performed mainly by computed tomography, and ultrasound is used for blood flow assessment. In two cases of PSS‐related hepatic encephalopathy, we used time‐resolved 3D cine phase‐contrast (4D‐flow) magnetic resonance imaging (MRI) to assess blood flow before and after shunt embolization. Before the intervention, blood flow in the main trunk of the superior mesenteric vein was mostly hepatofugal. However, post‐interventional 4D‐flow MRI revealed hepatopetal superior mesenteric vein flow with significantly increased portal vein blood flow. 4D‐flow MRI is an ideal adjunct to Doppler ultrasonography, allowing for objective and visual assessment of morphology and blood flow of the portal venous system, including PSSs, and is useful in determining the indications for, and outcome of, PSS embolization.


  • Open Access

    Portal Vein Stenosis Following Liver Transplantation Hemodynamically Assessed with 4D-flow MRI before and after Portal Vein Stenting

    by Ryota Hyodo, Yasuo Takehara, Takashi Mizuno, Kazushige Ichikawa, Yasuhiro Ogura, Shinji Naganawa

    We present a case of a patient who underwent portal vein (PV) stenting for PV stenosis after a living-donor liver transplantation. A pretreatment 3D cine phase-contrast (4D-flow) MRI showed decreased, though hepatopetal, blood flow in the PV. After stenting, 4D-flow MRI confirmed an improvement in PV flow, with a more homogeneous flow distribution to each hepatic segment. 4D-flow MRI are valuable for understanding the hemodynamics of this area, planning for treatments, and evaluating the outcome of the interventions.